Trypanosomiasis, human African sleeping sickness generally occurs in 36 sub-Saharan African countries. This disease is a vector-borne parasitic disease and is caused by an infection with protozoan parasites and transmitted to humans by the tsetse fly. This disease not only causes severe disruption in sleep patterns, but changes in behavior, confusion and without treatment the disease can ultimately lead to death. Health officials have reported about 1447 cases of African trypanosomiasis, but many believe that the true number of cases is believed to be much higher that what is reported. Treatments of the human African trypanosomiasis include drugs named eflornithine and nifurtimox, both treatments involve a complicated set of procedures including fusions and pills that are administered in a hospital.
Recent comments